COVID-19 Diagnostics Market By Product (Instruments, Kits & Reagents, Diagnostic Services), By Technology (Molecular assay, Immunological assay, Digital PCR (dPCR), Clustered regularly interspaced short palindromic repeats (CRISPR), Microarray), By Test Type (Antigen-based Testing, Antibody (Serology) Testing, Molecular (PCR) Testing, Others) By Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC) By End-User (Hospitals, Diagnostic Labs & Clinics, Healthcare Labs & Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

52560
Present Value (M$)
2019
145480
Forecast Value (M$)
2026
15.65%
CAGR (%)

The COVID-19 Diagnostics market is set for a rapid growth over the forecast period. In terms of revenue, the global COVID-19 Diagnostics market accounted for USD 52.56 Billion in 2019 and is expected to reach USD 145.48 Billion by 2026, growing at a CAGR of 15.65%.

Main companies

  • Hologic Inc.
  • Perkin Elmer
  • Veredus Laboratories
  • Thermo Fisher Scientific
  • F. Hoffman-La Roche Ltd.
  • 1drop Inc.
  • ADT Biotech Sdn Bhd
  • Neuberg Diagnostics
  • Luminex Corporation
  • Quidel Corporation
  • ALDATU BIOSCIENCES
  • Danaher
  • Mylab Discovery S